| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $43.3M | -6.0% |
| R&D Expense | $132.9M | +105.6% |
| SG&A Expense | $52.4M | +30.6% |
| Operating Income | -$145.9M | -94.3% |
| Pre-tax Income | -$130.8M | -84.9% |
| Income Tax | $90K | +8.4% |
| Net Income | -$130.9M | -84.9% |
| EPS (Basic) | -$2.32 | -27.5% |
| EPS (Diluted) | -$2.32 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $99.7M | -64.6% |
| Short-term Investments | $271.2M | +444.7% |
| Accounts Receivable | $607K | -24.6% |
| Inventory | $2.3M | -41.0% |
| Current Assets | $383.3M | +11.2% |
| Total Assets | $418.5M | +17.8% |
| Current Liabilities | $49.0M | -22.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$126.2M | -6832.1% |
| Capital Expenditures | $4.1M | +16.3% |
| Investing Cash Flow | -$219.4M | -6517.0% |
| Financing Cash Flow | $164.0M | -12.3% |
| Free Cash Flow | -$130.3M | -8001.9% |
| -27.5% |
| Total Liabilities |
| $82.0M |
| -7.8% |
| Stockholders' Equity | $336.5M | +26.4% |